SCHEMBL526181

SCHEMBL526181

N#Cc1[c]ccc(F)c1-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 3/20 0.35
ALOX15 P16050 2/20 0.35
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
ADORA2A P29274 3/20 0.33
ADORA1 P30542 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
HTT P42858 2/20 0.32
ADRA2A P08913 1/20 0.32
PDE9A O76083 1/20 0.32
PTPN1 P18031 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11796521 0.80 FASN (0.36) ALDH1A1HSD17B10ALOX15ADORA2AADORA1
SCHEMBL8013535 0.76 LMNA (0.36) ALDH1A1MAPTHTTLMNATTR
SCHEMBL15757626 0.75 LMNA (0.34) ALDH1A1MAPTHTTLMNATTR
SCHEMBL5182645 0.73 CYP1A2 (0.38) ALDH1A1ADORA2AADORA1MAPTHTT
SCHEMBL8658969 0.73 HTR1A (0.35) ALDH1A1KDM4EMAPTTSHRHPGD
SCHEMBL5321800 0.71 TNF (0.34) CYP11B1CYP11B2
SCHEMBL350376 0.70
SCHEMBL5664674 0.69 L3MBTL1 (0.39) ALDH1A1HSD17B10ALOX15ADORA2AADORA1
SCHEMBL9559560 0.69 ACHE (0.36) ADORA2AADORA1KDM4EMAPTHPGD
SCHEMBL30998042 0.69 HSD17B10 (0.45) ALDH1A1HSD17B10ALOX15ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013116491-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS AND METHODS FOR USING THEM RIGEL PHARMACEUTICALS, INC. (US) 2013-08-08 WO disclosed
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO disclosed